Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens

Table 6

PWV according to treatment protocols.

	Mean ± SD
Operation	Lumpectomy ()	7.2 ± 1.2	0.503
	Modified radical mastectomy ()	7.4 ± 1.3
Radiotherapy	Yes ()	7.2 ± 1.2	0.076
	No ()	8.2 ± 1.0
Chemotherapy	Anthracycline + trastuzumab	7.6 ± 1.0	0.428
	Anthracycline + taxane + trastuzumab	7.2 ± 1.3
Hormonotherapy	Yes ()	7.4 ± 1.2	0.434
	No ()	7.0 ± 1.4
Hormonotherapy type	Tamoxifen ()	6.5 ± 0.7	<0.01
	Aromatase inhibitor ()	8.3 ± 0.9

EC: epirubicin + cyclophosphamide; FEC: fluorouracil + Epirubicin + Cyclophosphamide.